Raynaud's phenomenon and Barrett's oesophagus

Summary:

Barrett's oesophagus is reported only by a few people with Raynaud's phenomenon.

The study analyzes which people have Barrett's oesophagus with Raynaud's phenomenon. It is created by eHealthMe based on 5 people who have Barrett's oesophagus and Raynaud's phenomenon from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

5 people who have Raynaud'S Phenomenon and Barrett'S Oesophagus are studied.

What is Raynaud's phenomenon?

Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas) is found to be associated with 1,525 drugs and 937 conditions by eHealthMe.

What is Barrett's oesophagus?

Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach) is found to be associated with 1,171 drugs and 584 conditions by eHealthMe.

Number of Barrett's oesophagus in Raynaud's phenomenon reports submitted per year:

Would you have Barrett's oesophagus when you have Raynaud's phenomenon?

Gender of people who have Raynaud'S Phenomenon and experienced Barrett'S Oesophagus *:

female: 60 %
male: 40 %

Age of people who have Raynaud'S Phenomenon and experienced Barrett'S Oesophagus *:

Common co-existing conditions for these people *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 40.00%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 20.00%
Interstitial Lung Disease: 1 person, 20.00%
High Blood Pressure: 1 person, 20.00%
High Blood Cholesterol: 1 person, 20.00%
Genital Herpes (herpes infection of genital): 1 person, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 20.00%
Dry Eyes (lack of adequate tears): 1 person, 20.00%
Depression: 1 person, 20.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Fatigue (feeling of tiredness): 3 people, 60.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 60.00%
Acute Myocardial Infarction (acute heart attack): 2 people, 40.00%
Disturbance In Attention: 2 people, 40.00%
Dyslipidaemia (abnormal amount of lipids): 2 people, 40.00%
Stress And Anxiety: 2 people, 40.00%
Sleep Disorder: 2 people, 40.00%
Emotional Distress: 2 people, 40.00%
Pain: 2 people, 40.00%
Libido Decreased (loss of interest in sex): 2 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Barrett's oesophagus?

Check whether Barrett's oesophagus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Raynaud's phenomenon (7,891 reports)
Barrett's oesophagus (7,656 reports)

COVID vaccines that are related to Barrett's oesophagus:

Common drugs associated with Barrett's oesophagus:

How the study uses the data?

The study is based on Barrett's oesophagus and Raynaud's phenomenon, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.